|Announcement Title||Change - Announcement of Appointment|
|Date & Time of Broadcast||Feb 19, 2020 18:56|
|Announcement Sub Title||Appointment of Executive Director - Dr. Cheng Ching Li|
|Submitted By (Co./ Ind. Name)||Chin Pak Lin|
|Designation||Executive Director and Chief Executive Officer|
|Description (Please provide a detailed description of the event in the box below)||Appointment of Executive Director - Dr. Cheng Ching Li
This announcement has been prepared by the Company and its contents have been reviewed by the Company's Sponsor, RHT Capital Pte. Ltd. (the "Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the "SGX-ST"). The Sponsor has not independently verified the contents of this announcement.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is: Name: Mr Mah How Soon, Registered Professional, RHT Capital Pte. Ltd. Address: 9 Raffles Place #29-01 Republic Plaza Tower 1, Singapore 048619 Tel: (65) 6381 6966.
|Date Of Appointment||19/02/2020|
|Name Of Person||Cheng Ching Li|
|Country Of Principal Residence||Singapore|
|The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)||The Board considered and accepted the Nominating Committee's recommendation to appoint Dr. Cheng as an Executive Director after reviewing his working experience.|
|Whether appointment is executive, and if so, the area of responsibility||Executive.
Dr. Cheng will assist the Company's Executive Director and Chief Executive Officer, Dr. Chin Pak Lin, in relation to the operations and the business operations of the enlarged group.
|Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)||Executive Director|
|Professional qualifications||Bachelor of Medicine, Bachelor of Surgery (MBBS) (Singapore)
Fellow of the Royal College of Surgeons (FRCS) Edinburgh
Masters of Medicine - Ophthalmology (MMed)
Fellow Academy of Medicine
|Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries||None|
|Conflict of interests (including any competing business)||None|
|Working experience and occupation(s) during the past 10 years||Dr. Cheng started private medical specialist practice in 2008 specialising in Ophthalmology before joining Cornerstone Asia Health Pte. Ltd. Group in 2017.
Dr. Cheng is a senior ophthalmic surgeon in Cataract and Comprehensive Ophthalmology. He also subspecialises in the fields of Vitreoretinal Medicine and Surgery, and Uveitis. Dr. Cheng is an active clinician, researcher and teacher, having presented over 50 talks in international and regional conferences. His current research focuses on dengue maculopathy and Fourier-domain Optical Coherent Tomography (OCT) scanning of the retina. He has published more than 20 peer-reviewed journals including Archives Ophthalmology, American Journal of Ophthalmology, British Journal of Ophthalmology and Retina.
|Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))||Yes|
|Shareholding interest in the listed issuer and its subsidiaries?||Yes|
|Shareholding Details||27,360,838 ordinary fully paid-up shares|
|# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).|
|Past (for the last 5 years)||Directorships
- Singapore Eye & Vision Pte. Ltd.
- Singapore Eye Specialists Centre Pte. Ltd.
- Bobcheng Pte. Ltd.
- Retina Services International Pte. Ltd.
- RSI Medical Pte. Ltd.
- Cornerstone Asia Health Pte. Ltd.
|(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?||No|
|(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?||No|
|(c) Whether there is any unsatisfied judgment against him?||No|
|(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?||No|
|(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?||No|
|(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?||No|
|(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?||No|
|(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?||No|
|(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?||No|
|(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-|
|(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or||No|
|(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or||No|
|(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or||No|
|(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?||No|
|(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?||No|
|Any prior experience as a director of an issuer listed on the Exchange?||No|
|If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange||Dr. Cheng had attended "Listed Entity Director Essentials" conducted by the Singapore Institute of Directors on 8 November 2018. The Company will arrange for Dr. Cheng to receive relevant training as a director of a listed company in Singapore.|
|Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)||Not applicable.